COVID-related Acute Limb Ischemia: The Indian Data

Author:

Jha Manvendu1,Pawar Pranay2,Samuel Vimalin3,Stephen Edwin4,Bedi Varinder Singh5,Suresh Kalkunte6,Sritharan T N7,Ilayakumar P7,Sahu Tapish8,Thakore Vijay9,Sekhar Raghuram10,Subramanian Sairam1112,Sekar Natarajan13,Jagan Jithin13,Raju Radhakrishnan14,George Robbie15

Affiliation:

1. Department of Vascular Surgery, Army Hospital, Srinagar, Jammu and Kashmir, India

2. Department of Vascular Surgery, Christian Medical College and Hospital, Ludhiana, Punjab, India

3. Department of Vascular Surgery, Christian Medical College and Hospital, Vellore, Tamil Nadu, India

4. Department of Vascular Surgery, Sultan Qaboos University Hospital, Seeb, Oman

5. Department of Vascular Surgery, Sir Ganga Ram Hospital, New Delhi, India

6. Department of Vascular Surgery, Jain Institute of Vascular Sciences, Bengaluru, Karnataka, India

7. Department of Vascular Surgery, Madras Medical College, Chennai, Tamil Nadu, India

8. Department of Vascular Surgery, Medanta The Medicity, Gurgaon, Haryana, India

9. Department of Vascular Surgery, Aadicura Superspeciality Hospital, Vadodara, Gujarat, India

10. Department of Vascular Surgery, Kokilaben Dhirubhai Ambani Hospital, Mumbai, Maharashtra, India

11. Department of Vascular Surgery, Sundaram Medical Foundation, Chennai, Tamil Nadu, India

12. Department of Vascular Surgery, SIMS Hospital, Chennai, Tamil Nadu, India

13. Department of Vascular Surgery, Kauvery Hospital, Chennai, Tamil Nadu, India

14. Department of Vascular Surgery, Sri Ramachandra Insititute of Higher Education and Research, Chennai, Tamil Nadu, India

15. Department of Vascular Surgery, Narayana Hrudayalaya, Bengaluru, Karnataka, India

Abstract

Introduction and Objective: The reported incidence of COVID-related acute limb ischemia (CRALI) ranged from 3.7% to 9.6% in the literature. We report on consolidated data of patients with CRALI from 21 centers across India, which spanned the first two waves of COVID-the period of May 2020 to June 2021. Materials and Methods: Study design: Multicenter study from May 2022 to June 2021. Retrospective analysis of prospectively collected data was done. Inclusion criteria: All patients who presented with signs and symptoms of acute limb ischemia or acute on chronic limb ischemia and who also tested positive for COVID through rapid antigen test or real time polymerase chain reaction. Results: Data for 268 patients from 21 centers across India was available for analysis. 71% were males and 85% were >45 years of age. Majority of patients (n = 191) presented with acute symptoms. Best medical management with antiplatelets and anticoagulants was the only treatment in 34% of patients. Open embolectomy was attempted in 42%, endovascular procedures in 8% and amputation as primary procedure in 14.5%. Higher grades of ischemia were associated with significantly poorer limb salvage, amputation and mortality in the immediate and 14 days follow up (P < 0.001). At 14 days 173 limbs were salvaged (64.5%). Eighty patients underwent amputations (29.8%); 26 of the 80 (32%) were minor amputations (trans-metatarsal and less), so the major amputation rate was 20.1%. Maximum number of deaths were in the group that had undergone medical management (23%), while the least number of deaths were seen in the patients that had undergone some form of intervention, open surgical (2%) or endovascular procedure (4%). Looking at 14-day outcomes, the numbers of deaths in the patients managed with medical methods increased to 30%, open surgical to 7% and endovascular procedures to 8%. Conclusion: CRALI presented both as a primary presentation or developed later during the disease. Early surgical and endovascular interventions in these patients can help in achieving decent limb salvage rates.

Publisher

Medknow

Subject

General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3